Please see our blog post from Canadian members of our research consortium on developments towards a Canadian national rare disease policy, its challenges, potentialities, and continued need for social pharmaceutical innovation: https://www.socialpharmaceuticalinnovation.org/post/is-price-capping-an-answer-for-expensive-drugs-for-rare-diseases-in-canada
top of page
bottom of page